Zichu Zhao
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Characterization and associated risk factors of Pneumocystis jirovecii pneumonia in patients with AIRD: a retrospective study.
Journal: Rheumatology (Oxford, England)
Published: September 21, 2021
The off-label uses profile of tofacitinib in systemic rheumatic diseases.
Journal: International immunopharmacology
Published: January 27, 2020
Deguelin induced differentiation of mutated NPM1 acute myeloid leukemia in vivo and in vitro.
Journal: Anti-cancer drugs
Published: May 05, 2017
Steroid receptor coactivator-3 is a pivotal target of gambogic acid in B-cell Non-Hodgkin lymphoma and an inducer of histone H3 deacetylation.
Journal: European journal of pharmacology
Published: May 26, 2016
miR-137 Suppresses the Phosphorylation of AKT and Improves the Dexamethasone Sensitivity in Multiple Myeloma Cells Via Targeting MITF.
Journal: Current cancer drug targets
Published: June 20, 2015
Oridonin, a promising antitumor natural product in the chemotherapy of hematological malignancies.
Journal: Current pharmaceutical biotechnology
Published: September 05, 2014
Nontoxic-dose of deguelin induce NPMc+ AML cell differentiation by selectively targeting Mt NPM1/SIRT1 instead of HDAC1/3.
Journal: Current cancer drug targets
Published: July 25, 2014
Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation.
Journal: Annals of hematology
Published: May 20, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026